Amisulpride Rivopharm 200 mg
Amisulpride Rivopharm 200 mg is a medicine authorised by Swissmedic under authorisation number 59999. The authorisation holder is Rivopharm SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 June 2010 and the authorisation is valid without a time limit. The export lists no ATC code for this medicine.
| Authorisation number | 59999 |
|---|---|
| Name | Amisulpride Rivopharm 200 mg |
| Full name | Amisulpride Rivopharm 200 mg, compresse |
| Authorisation holder | Rivopharm SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | not stated |
| First authorisation | 22 June 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Amisulpride Rivopharm 200 mg, compresse | B | 22 June 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Amisulpride Rivopharm 200 mg authorised in Switzerland?
Yes. Amisulpride Rivopharm 200 mg is authorised by Swissmedic under authorisation number 59999, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amisulpride Rivopharm 200 mg have?
Amisulpride Rivopharm 200 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Amisulpride Rivopharm 200 mg?
The authorisation holder is Rivopharm SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.